Form D · Biotechnology

NERITES CORP

Madison, WI · CIK 0001339837

Offering snapshot reported Feb 3, 2010 · SEC filing

Reported sold
$600K
Offering amount: $1.28M
Investors reported
4
Form D · investor count
Minimum accepted
$3.63K
Reported outside-investor minimum
First sale
Jan 20, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 3, 2010Initial$600,000No comparison4SEC filing
Jun 11, 2009Initial$1,669,779No comparison16SEC filing
Mar 4, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Nov 13, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 18, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Apr 10, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Apr 3, 2006PaperNot reportedNo comparisonNot reported
Sep 23, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-81552

Source: Form D, filed Feb 3, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
George Arida Director, Executive
Philip Blake Director
Walter Dewey Director
Lisa Earnhardt Director
Richard Leazer Director
Shaun C. Lonergan Director, Executive
Phil Messersmith Director
Thomas J. Mozer Director, Executive
James C. Powell Director
David C. Sneider Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
525 Science Drive, Suite 215
Madison, WI, 53711